Estonia’s ride-sharing service provider Bolt launches e-scooter in 45 cities

On Wednesday, Estonia’s Bolt, a ride-sharing service provider, launched its own electric scooter model with the aim of launching the scooter service in more than 45 cities this summer. The Estonian company has grabbed business from Uber in many major African and Eastern Europe cities. Bolt has more than 30 million users in over 35…

WeWork co-founder Adam Neumann files lawsuit against SoftBank Group Corp and its Vision Fund against wrongful termination of tender

Adam Neumann, WeWork’s co-founder has filed a lawsuit against SoftBank Group Corp and against its Vision Fund for terminating a $3 billion tender offer to the office-sharing startup’s shareholders. In October, the tender was part of a $9.6 billion financial rescue package that SoftBank had agreed to, following which WeWork gave it control of the…

Low Lockdown Compliance In US, Australia, While Other Countries Stayed Home, Shows Google Travel Data

According to analysis of data from Google, a large number of people in Brazil, Japan and Singapore in April stayed home amid the rising number of cases being reported from these countries while residents in the United States and Australia violated lockdown orders and flocked to parks and jobs with the flattening of infection rates…

Alleged hacker puts up Tokopedia’s user details for sale on darknet

Indonesia’s largest e-commerce platform, Tokopedia said, it is investigating an attempted cyber attack and claims that details of millions of its users had been leaked online. “We found that there had been an attempt to steal data from Tokopedia users,” said Tokopedia’s spokesman. “However, Tokopedia ensures that crucial information such as passwords remains successfully protected…

Gilead Sciences Inc to ramp up production of experimental COVID-19 treatment with international partners

In a statement Gilead Sciences Inc, the maker of the closely-watched experimental coronavirus drug remdesivir stated, it will continue to work with international partners to expand the production of its potential COVID-19 treatment. Gilead said, it expects to have more than one million remdesivir treatment courses manufactured by December, “with plans to be able to…